We are an emerging leader with new solutions in the field of nuclear medicine technology

Explore Our Company

Products

Products

Our innovative products and technologies are designed to meet current and future demands for medical radioisotopes. They mark a new era for nuclear medicine technology.

Supply

Supply

Medical radioisotopes are critical to meet patient healthcare needs and advance clinical research. We’ve charted the course for producing a stable, reliable and domestically sourced isotope supply.

Commitment

Commitment

Our people drive our solutions. From providing domestic supply of isotopes for patients to national security and environmental sustainability, we are committed to advancing radioisotope technology to shape a better world.

About NorthStar

We are a nuclear medicine technology company committed to providing the United States with stable, domestic and environmentally friendly radioisotope supply solutions to meet the needs of patients and advance clinical research.  Our innovative technologies have the ability to fundamentally transform the ways that medical radioisotopes are produced and distributed around the world.

Learn More About NorthStar

Press Releases
November 27, 2019
NorthStar Medical Radioisotopes Marks 12 Months of Continuous U.S. Molybdenum-99 (Mo-99) Production and Supply

− RadioGenix® Systems have enabled reliable technetium 99m (Tc-99m) supply for patients’ diagnostic imaging procedures since product launch, despite ongoing industry supply shortages – Beloit, Wis., November 27, 2019 – NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, announced a landmark for its RadioGenix System (technetium 99m generator) product and success in its efforts to provide the United States with dependable radioisotope supply.

Read More
Press Releases
October 15, 2019
Representatives from the U.S. Department of Energy’s National Nuclear Security Administration, State of Wisconsin, Medical Societies and Customers Join NorthStar Medical Radioisotopes’ Groundbreaking and Speaker Event

– Marking NorthStar expansion progress to increase U.S. production of non-highly enriched uranium produced molybdenum-99 (Mo-99), used in producing important medical isotope technetium-99m (Tc-99m) ‒ ‒ Recognizing RadioGenix® System contributions in addressing ongoing Mo-99 supply shortages by providing customers with nearly a year of continuous medical radioisotope supply since launch ‒ Beloit, Wis., October 14, 2019 – NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, announced that it hosted a ribbon-cutting, groundbreaking and speakers event, “Molybdenum-99: Domestic Radioisotope Production Now, Expansion for the Future,” at its headquarters in Beloit, Wis.

Read More
Press Releases
August 28, 2019
NorthStar Medical Technologies to Present at Upcoming Atoms for Humanity Summit

‒ Panel to discuss domestic Tc-99m radioisotope production, role of nuclear diagnostics and treatments in advancing personalized medicine – BELOIT, Wis.

Read More

How Can We Help?

Questions about company, products, supply solutions, careers or anything else?

Contact Us Today